Novan announced that its commercial subsidiary, EPI Health, will now unify under one brand name, Novan. "Since the closing of our acquisition of EPI Health in March of 2022, we have made significant progress integrating our organizations into one cohesive business. As of today, we are pleased to move forward as one united brand, Novan, with the unified goal of building a premier medical dermatology company. We believe our integrated business will streamline our pre-commercial activities for berdazimer gel, 10.3%," commented Paula Brown Stafford, President and Chief Executive Officer of Novan.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NOVN:
